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possibility of long-term immunological rejection of the allograft. In the fu-
ture, it will be necessary to carry out these studies using an autograft model.
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REPEATED SUB-THRESHOLD DOSING OF TGF-BETA1 IS INEFFECTIVE IN
STIMULATING HUMAN BONE MARROW CELLS: IMPLICATIONS FOR
CARTILAGE REPAIR STRATEGIES
V. Yao, K.A. Payne, C.R. Chu
Univ. of Pittsburgh, Pittsburgh, PA
Purpose: Articular cartilage injury and degeneration are leading causes
of disability. Since the articular cartilage has a limited capability to heal
itself, improving cartilage repair is an important strategy to reducing
pain and disability. Transforming growth factor-beta 1 (TGF-β1) induces
chondrogenesis of human bone marrow cells (hBMC), an important cell
source for cartilage repair. A challenge to in vivo administration of TGF-β1
is understanding the dosing regimens that would effectively stimulate
hBMC and improve cartilage repair. The aims of this study are to test the
hypothesis that (1) TGF-β1 signaling can be induced and maintained by
either single or repeated administrations in vitro, and (2) hBMC mediated
cartilage repair cells remain responsive to sustained exposure to TGF-β1 in
vivo.
Methods: To test hypothesis 1, hBMC were stimulated with single admin-
istration of 5, 10 or 15ng/mL of TGF-β1 and the expression of TβRII and
phospho-SMAD3 compared with multiple administrations of TGF-β1 by
Western Blot. Protein was isolated at 0, 2h, 4h, 1d, 3d and 7d after the last
administration of TGF-β1.
To test hypothesis 2, TβRII expression were assessed in athymic rat osteo-
chondral defects at 4 weeks following implantation of hBMC transduced
with AAV-GFP or AAV-TGF-β1 by immunohistochemical staining.
Results: In vitro, TβRII expression increased signiﬁcantly at 2h post-
stimulation with single administration of 15ng/mL of TGF-β1, and at 4h
and 1d post-stimulation with single administration of 10ng/mL of TGF-β1.
Phospho-SMAD3 expression increased at 2h post-stimulation with single
administration of 10ng/mL of TGF-β1. However, the expression of both pro-
teins declined thereafter. In contrast, multiple administrations of 10ng/mL
of TGF-β1 led to increases in TβRII and phospho-SMAD3 expression for up
to 7 days post-stimulation.
In vivo, TβRII was strongly expressed throughout the repair tissues of
osteochondral defects receiving hBMC expressing TGF-β1, but there was
weak and sparse expression of TβRII in repair tissues of osteochondral
defects receiving hBMC expressing GFP.
Conclusions: The data show that the effects of single administration of
TGF-β1 in vitro are transient suggesting that repetitive administrations of
10ng/mL of TGF-β1 may be required to sustain cellular responsiveness
in vivo. In vivo, cartilage repair cells remain responsive to repeated ex-
posure to TGF-β1. The implication for in vivo repair strategies are that
sustained exposure of hBMC to TGF-β1 is critical and can be achieved using
AAV-vectors.
178
ANTAGONIZING ENDOGENOUSLY EXPRESSED BONE MORPHOGENETIC
PROTEINS IMPAIRS CARTILAGE EXTRACELLULAR MATRIX
REPLENISHMENT IN VITRO
I.-G. Sunk, L. Amoyo, J.S. Smolen, K. Bobacz
Med. Univ. of Vienna, Vienna, Austria
Purpose: To investigate the role of bone morphogenetic proteins (BMP) in
intrinsic cartilage repair following tissue damage.
Methods: Cartilage explants were obtained from metacarpophalangeal
joints of adult steers. Cartilage damage was induced by depleting extracel-
lular matrix by trypsin digestion. Samples were maintained in serum-free
basal medium (BM) with and without the addition of either Noggin, Noggin
+ insulin-like growth factor (IGF)-I and Noggin + Fetal calf serum (FCS).
Undigested and unstimulated explants served as negative controls. At days
7, 14, 21, 28 and 35 biosynthesis of matrix macromolecules was assessed
by [35S]Sulfate incorporation. Additionally, histological analysis using tolu-
idine blue staining and quantitative real-time PCR on distinct BMPs was
performed.
Results: Endogenous expression of BMPs was upregulated following car-
tilage damage; simultaneously, matrix macromolecule synthesis was in-
creased. Blocking of BMP activity using the BMP-antagonist Noggin resulted
in a signiﬁcant reduction of glucosaminoglycan neo-synthesis. While FCS
overcame the anti-anabolic effects of Noggin, the addition of IGF-I had no
signiﬁcant stimulatory effect on matrix macromolecule production.
Conclusions: We conclude that the increased expression of BMPs af-
ter cartilage damage together with a BMP-dependent increase in matrix
macromolecule synthesis indicates a functional role of these growth factors
in intrinsic cartilage repair.
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AUTOLOGOUSMATRIX INDUCED CHONDROGENESIS (AMIC PLUS) FOR
THE TREATMENT OF PATELLAR CARTILAGE DEFECTS IN THE KNEE
A.A. Dhollander, F. De Neve, F. Almqvist, R. Verdonk, P.C. Verdonk
Ghent Univ., Ghent, Belgium
Purpose: The present study was designed to evaluate the AMIC plus
technique for the treatment of symptomatic patellar cartilage defects in the
knee. MRI was used for the morphological analysis of cartilage repair.
Methods: The AMIC plus technique (combination of the original AMIC tech-
nique and the use of platelet rich plasma) was used for the treatment of
symptomatic chondral and osteochondral patellar lesions in the knee. Five
patients were clinically prospectively evaluated with use of the Knee Injury
and Osteoarthritis Outcome Score (KOOS), a Visual Analogue Scale (VAS) for
pain, the Tegner activity level scale and Kujala scale preoperatively and at
12 and 24 months of follow-up. All 5 patients had consented to follow the
postoperative MRI evaluation protocol. MRI data were analyzed based on
the original MOCART (Magnetic Resonance Observation of Cartilage Repair
Tissue) scoring system.
Results: A statistically signiﬁcant clinical improvement became apparent
after 24 months of follow-up. The MOCART scoring system revealed no
signiﬁcant deterioration or improvement of the repair tissue between
one and two years of follow-up. Twenty-four months after the operation
hypertrophy was found in 40%. Subchondral bone changes and intralesional
osteophytes were seen in all cases (100%). Synovitis and adhesions were
not observed in the study patients at that time of follow-up.
Discussion: AMIC plus resulted in clinically signiﬁcant improvement in all
patients. The favourable clinical outcome of the AMIC plus technique was
not conﬁrmed by the MRI ﬁndings as determined by the MOCART score.
More speciﬁcally, all cases showed subchondral lamina and bone changes,
including intralesional osteophytes, were observed.
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HIGH-THROUGHPUT TRANSCRIPTION PROFILING REVEALS CANDIDATE
GENES INVOLVED IN REGENERATION AFTER EXPERIMENTAL JOINT
DAMAGE IN THE NEWT
M. Geyer1, T. Borchardt2, C. Michel2, C. Schreiyäck1, U. Müller-Ladner1,
R. Dinser1
1Justus-Liebig-Univ. of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany;
2Max-Planck-Inst. for Heart and Lung Res., Bad Nauheim, Germany
Purpose: In contrast to mammal joint injuries that cannot be treated
causatively so far, amphibians are able to regenerate whole limbs and can
endogenously cure local articular tissue lesions. Therefore, we aimed to de-
cipher regeneration-relevant molecular factors by analyzing the differential
gene expression proﬁle of damaged vs. intact knee joints of adult newts
using cDNA array technology.
Methods: Knee joint damages of adult newts (Notophthalmus viridescens)
were induced by surgical removal of the femoral cartilage. After total
RNA isolation from whole knee joints at different time points after dam-
age hybridization onto cDNA microarrays was performed, and selected
differentially expressed genes are being validated by PCR techniques.
Results: Based on the array spots usable for analysis after hybridization,
we ﬁltered those genes that were at least 2-fold differentially expressed in
at least 3 of 4 replicates in the same direction. Accordingly, 26, 22 and 3
as well as 4, 11 and 9 known genes and many unknown transcripts were
found to be up- or downregulated at days 10, 20 and 40, respectively.
Amongst known genes, there were matrix components (decorin, biglycan,
ﬁbronectin, collagens, tenascin), anabolic and catabolic factors (e. g. TIMP,
MMPs, cathepsins) as well as different signalling molecules. First PCR
validations conﬁrmed the gene expression differences between damaged
and intact joints.
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Conclusions: Many genes are relevant for the regeneration of joint damage
in the newt. Some are well known and can also be found in mammals.
Functional validations might help to move closer towards novel therapies
at least in part also driven by endogenously induced regeneration.
Cartilage/Chondrocyte Biology
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INTERLEUKIN 1 β (IL-1β) AND RESISTIN STIMULATE CHEMOKINE GENE
EXPRESSION BY ORDERED COMBINATORIAL BINDING OF TRANSCRIPTION
FACTORS C/EBPβ AND NF-κB
Z. Zhang1,2, J.L. Bryan1, E. DeLassus1, L.J. Sandell1
1Washington Univ. Sch. of Med., St.Louis, MO; 2First Aﬃliated Hosp. of Sun
Yat-sen Univ., Guangzhou, China
Purpose: IL-1β and the adipokine, resistin, are present in synovial joints
after injury. In vitro they stimulate a large set of chemokines which, as
mediators of cell recruitment, are known to be important in inﬂamma-
tory diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA).
Toward the goal of regulating early events that lead to osteoarthritis, we
have investigated the mechanism by which chemokines are up regulated
in human articular chondrocytes.
Methods: Human articular chondrocytes were used to investigate the
response to IL-1β and the adipokine, resistin. The expression of
CCAAT/enhancer-binding protein β (C/EBPβ), and nuclear factor kappa
B (NF-κB) isoforms, p50, p65, rel-B, c-rel, were tested by quantitative
real-time polymerase chain reaction (qPCR) and western blotting. The
function of C/EBPβ and NF-κB on the chemokine genes, CCL3 and CCL4,
was examined by electrophoretic mobility shift assays (EMSA), chromatin
immunoprecipitation (ChIP), mutation, small interfering RNAs (siRNA),
pNF-κB reporter transfection, and NF-κB inhibitor (IKK-NBD) and C/EBPβ
inhibitor (SB303580) treatments. The co-regulation of C/EBPβ and NF-κB in
time was investigated by transfection, speciﬁc inhibition, and subcellular
localization with or without IL-1β and resistin stimulation.
Results: IL-1β and resistin are additive in their regulation of chemokine
genes. The expression of C/EBPβ and NF-κB isoforms, c-rel and p50, were
increased by IL-1β and resistin in human chondrocytes. The direct in-
volvement of C/EBPβ and NF-κB was demonstrated by DNA binding and
mutation of the binding domain in target genes, CCL3 and CCL4. C/EBPβ
regulated basal activity and the binding steadily increased over time up
to 24 hrs with IL-1β or resistin. In contrast, NF-κB did not regulate basal
activity of CCL3 and CCL4, but was up-regulated upon induction with IL-1β
or resistin, peaking at 8 hrs. C/EBPβ and NF-κB co-enhance the CCL3 and
CCL4 expression and inhibition of C/EBPβ or NF-kB activity was additive.
Figure 1. Subcellular localization of C/EBPβ and NF-κB isoform c-Rel in reponse to IL-1β (1
ng/ml) and resistin (100 ng/ml).
Figure 2. The potential transcriptional model for the up-regulation of chemokine genes in
human chondrocytes.
The timing of transcription factor activation in chondrocytes was conﬁrmed
by subcellular localization of C/EBPβ and c-rel by immunoﬂuorescence
microscopy (Fig. 1). A model of this regulation is shown in Fig. 2.
Conclusion: IL-1β and resistin both play a role in induction of chemokine
synthesis. The transcription factors, C/EBPβ and NF-κB are both involved
in the up-regulation of chemokine genes in human chondrocytes in a
time-ordered manner: NF-κB provides an initial up regulation and C/EBPβ
sustains increased gene expression. Thus, regulation of inﬂammation in
OA will need to account for resistin as well as IL-1β and the function
of C/EBPβ as well as NF-κB in gene regulation. Our results suggest that
chemokine genes in tissues such as cartilage, may be regulated differently
than in inﬂammatory cascades in circulating cells with more emphasis
on control by transcription factors other than NF-κB, particularly C/EBPβ.
Lastly, a newest report indicates that mice lacking C/EBPβ are protected
from OA. Our results shed light on the mechanism of action of this pivotal
transcription factor.
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INHIBITION OF HYPOXIA-INDUCIBLE FACTOR TARGETTING PROYL
HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2 (PHD2) ENHANCES
MATRIX SYNTHESIS BY HUMAN CHONDROCYTES
B.L. Thoms, C.L. Murphy
Kennedy Inst. of Rheumatology. Imperial Coll. London, London, United
Kingdom
Purpose: Human articular cartilage is an avascular tissue, and therefore
functions in a hypoxic environment. Chondrocytes have adapted to this and
actually use hypoxia to drive tissue-speciﬁc functions. We have previously
shown that hypoxia enhances cartilage matrix synthesis in human chon-
drocytes, speciﬁcally through Hypoxia Inducible Factor 2-alpha (HIF-2α)
mediated upregulation of master regulator transcription factor SOX9, which
in turn drives expression of the main cartilage-speciﬁc extracellular matrix
genes. Under normoxic conditions the HIF-α subunit is hydroxylated on
speciﬁc conserved proline residues by proyl-hydroxylase domain enzymes
(PHDs). This hydroxylation signals the α-subunit’s polyubiquitination and
subsequent degradation. PHDs are the direct oxygen sensors of the cell
requiring molecular oxygen as a co-substrate. Here we have investigated
the regulation of HIF-α isoforms by hydroxylases using siRNA against
PHD1/PHD2/PHD3 with the aim of stabilising HIF-2α, up-regulating SOX9
and increasing cartilage matrix deposition.
Methods: Healthy human articular chondrocytes (HACs) were cultured as
a monolayer at 20% or 1% oxygen. Hydroxylases were broadly inhibited
using either dimethyloxalylglycine (DMOG) or speciﬁcally inhibited using
siRNA. The resulting HIF-α stabilization was assessed using western blot
and the expression of chondrocyte markers (SOX9) and key cartilage
extracellular matrix proteins (COL2A1, COL9A1, COL11A2 and AGGRECAN)
using real-time PCR and western blot.
Results: We report the successful knockdown of PHD1/2/3 in freshly
isolated and passaged chondrocytes. PHD2 was identiﬁed as the dominant
isoenzyme in HACs regulating HIF-2α stability in human chondrocytes.
Moreover, speciﬁc inhibition of PHD2 using RNAi-mediated depletion
